2 FEBRUARY 2006

NEW ZEALAND GAZETTE, No. 10

5% or less and more than 1%; for oral use in medicines
containing more than 50 milligrams per recommended
daily dose and in packs containing more than 250
milligrams of phenylephrine per pack
Podophyllotoxin; for external use for the treatment of warts
other than anogenital warts in medicines containing
0.5% or less
Podophyllum emodi; for external use for the treatment
of warts other than anogenital warts in medicines
containing 10% or less of podophyllin
Podophyllum peltatum; for external use for the treatment
of warts other than anogenital warts in medicines
containing 10% or less of podophyllin
Potassium chlorate; except in medicines containing 10% or
less
Prilocaine; for dermal use in medicines containing 10% or
less
Promethazine; for oral use when combined with one or more
other therapeutically active substances for the treatment
of coughs, colds or influenza when at least one of
the other therapeutically active substances is a
sympathomimetic decongestant or in a day/night pack
containing promethazine in the bedtime dose and in
preparations for adults or children two years of age or
more; in a sealed container of not more than 10 tablets
or capsules for the prevention or treatment of motion
sickness except when sold at a transport terminal or
aboard a ship or plane
Propamidine; for ophthalmic use
Pyrithione zinc; for external use in medicines containing
more than 2%
Sabadilla; in packs containing 18 milligrams or less of
total alkaloids except in packs containing 1.8 milligrams
or less and a recommended daily dose of not more than
0.6 milligrams of total alkaloids
Silver; except in oral solutions containing 0.3% or less or
other medicines containing 1% or less
Silver sulfadiazine; for external use in packs containing
50 grams or less
Sodium picosulfate; for laxative use
Stramonium; in solid dose form in medicines containing
0.3 milligrams or less per dose and 1.2 milligrams or less
per recommended daily dose
Thenyldiamine; for nasal use; for oral use when combined
with one or more other therapeutically active substances
for the treatment of coughs, colds or influenza when at
least one of the other therapeutically active substances is
a sympathomimetic decongestant or in a day/night pack
containing thenyldiamine in the bedtime dose and in
preparations for adults or children two years of age or
more
*Triamcinolone; in aqueous nasal sprays delivering up to
55 micrograms per actuation when the maximum daily
dose is no greater than 220 micrograms and the medicine
has received the consent of the Minister or the
Director-General to its distribution as a pharmacy-only
medicine
Trimeprazine; for oral use when combined with one or
more other therapeutically active substances for the
treatment of coughs, colds or influenza when at least one
of the other therapeutically active substances is a
sympathomimetic decongestant or in a day/night pack
containing trimeprazine in the bedtime dose and in
preparations for adults or children two years of age or
more
Triprolidine; for oral use when combined with one or
more other therapeutically active substances for the
treatment of coughs, colds or influenza when at least one

193

of the other therapeutically active substances is a
sympathomimetic decongestant or in a day/night pack
containing triprolidine in the bedtime dose and in
preparations for adults or children two years of age or
more

Medicines for General Sale

Please note that the following medicines are no longer
classified as prescription medicines, restricted medicines or
pharmacy-only medicines. As such, they are now available
for general sale.

Acetylcysteine; for external use; for oral use in medicines
containing 1 gram or less per recommended daily dose
Aciclovir; for external use for the treatment of herpes
labialis in medicines containing 5% or less and in tubes
containing 10 grams or less
Acriflavin
Bamyphylline
Benzamine
Benzyl benzoate
Bifonazole; for external use in medicines for tinea pedis
only or in shampoos containing 1% or less
Butyl aminobenzoate; in medicines for dermal use
containing 2% or less
Collagen; except in injections or implantations for tissue
augmentation or cosmetic use
Dextromethorphan; in liquid form containing 0.25% or less
or in solid dose form containing 15 milligrams or
less per dose form when in packs containing not more
than 600 milligrams and with a recommended daily dose
of not more than 120 milligrams
Dichlofenthion
Diprophylline
Ephedra navadensis
Fluorides; in pastes, gels or powders for cleaning the
teeth containing 0.1% or less; in parenteral nutrition
replacement preparations; in oral hygiene products
other than pastes, gels or powders for cleaning the teeth
containing 220 milligrams or less per litre or per
kilogram and in packs containing not more than 120
milligrams of total fluoride; in other medicines
containing 15 milligrams or less per litre or per kilogram
Folic acid; for oral use in medicines containing 500
micrograms or less per recommended daily dose
Folinic acid; for oral use in medicines containing 500
micrograms or less per recommended daily dose
Gadobenic acid
Gadobutrol
Guaiphenesin; for oral use in medicines containing 2% or
less or 200 milligrams or less
Hyaluronic acid; except in injections or implantations for
tissue augmentation or cosmetic use
Hydroquinone; for external use in hair preparations
containing 1% or less
Hylan polymer; except injections or implantations for tissue
augmentation or cosmetic use
Hyoscyamus niger; in packs containing 30 micrograms or
less of total solanaceous alkaloids
*Ibuprofen; for external use; for oral use in solid dose form
containing 200 milligrams or less per dose form when in
packs containing not more than 25 dose units and when
in medicines which have received the consent of the
Minister or the Director-General to their sale as general
sale medicines and which are sold in the manufacturer’s
original pack
Injectable medicines; except when specified in the First
Schedule to the Medicines Regulations